Weed (BUDZ) Depreciation & Amortization - Total (2020 - 2026)
Weed (BUDZ) recorded quarterly Depreciation & Amortization - Total of $4972.0 in Q1 2026, up 150.01% quarter-over-quarter from -$9943.0 in Q4 2025, and down 11.56% on a YoY basis from $5622.0 in Q1 2025.
Weed (BUDZ) Depreciation & Amortization - Total (2020 - 2026) Analysis & Trends
Weed's Depreciation & Amortization - Total history runs 7 years deep, the most recent figure standing at $4972.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization - Total fell 11.56% year-over-year to $4972.0; the TTM figure through Mar 2026 stood at $4322.0 (down 78.96% YoY), while the FY2025 annual figure was $4972.0, down 75.12% from the prior year.
- Depreciation & Amortization - Total was $4972.0 for Q1 2026 at Weed, up from -$9943.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $34377.0 in Q1 2022 to a low of -$9943.0 in Q4 2025.
- Historically, Depreciation & Amortization - Total has averaged $10931.9 across 5 years, with a median of $5071.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization - Total soared 33.98% in 2024, then tumbled 299.98% in 2025.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $23163.0 in 2022, then slumped by 83.98% to $3711.0 in 2023, then jumped by 33.98% to $4972.0 in 2024, then sank by 299.98% to -$9943.0 in 2025, then jumped by 150.01% to $4972.0 in 2026.
- The last three Depreciation & Amortization - Total figures came in at $4972.0 (Q1 2026), -$9943.0 (Q4 2025), and $4972.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Weed | - | - | - | 4,972.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,972.00 |
| Dec 31, 2025 | -9,943.00 |
| Sep 30, 2025 | 4,972.00 |
| Jun 30, 2025 | 4,321.00 |
| Mar 31, 2025 | 5,622.00 |
| Dec 31, 2024 | 4,972.00 |
| Sep 30, 2024 | 4,971.00 |
| Jun 30, 2024 | 4,972.00 |
| Mar 31, 2024 | 5,071.00 |
| Dec 31, 2023 | 3,711.00 |
| Sep 30, 2023 | 5,121.00 |
| Jun 30, 2023 | 16,929.00 |
| Mar 31, 2023 | 24,030.00 |
| Dec 31, 2022 | 23,163.00 |
| Sep 30, 2022 | 20,605.00 |
| Jun 30, 2022 | 27,977.00 |
| Mar 31, 2022 | 34,377.00 |
| Dec 31, 2021 | 34,554.00 |
| Sep 30, 2021 | 32,834.00 |
| Jun 30, 2021 | 27,169.00 |